SageView Advisory Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
5,159
+1
+0% +$208 0.04% 222
2026
Q1
$1.09M Sell
5,158
-214
-4% -$46.1K 0.04% 224
2025
Q4
$1.1M Sell
5,372
-171
-3% -$32.2K 0.04% 242
2025
Q3
$870K Buy
5,543
+116
+2% +$17.9K 0.03% 285
2025
Q2
$848K Buy
5,427
+199
+4% +$29.5K 0.03% 266
2025
Q1
$720K Buy
5,228
+1,450
+38% +$185K 0.03% 275
2024
Q4
$447K Buy
+3,778
New +$441K 0.02% 365

Other funds holding CAH

SageView Advisory Group's CAH Position: Q2 2026 in Review

SageView Advisory Group increased its Cardinal Health (CAH) stake by 0.02% in Q2 2026, buying an estimated $208 and bringing the position to 5,159 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #222.

SageView Advisory Group first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • SageView Advisory Group held 5,159 shares of Cardinal Health worth $1.23M as of Q2 2026.
  • SageView Advisory Group bought 1 Cardinal Health share in Q2 2026, an estimated $208.
  • Cardinal Health made up 0.04% of SageView Advisory Group's portfolio in Q2 2026, its #222 holding.
  • SageView Advisory Group first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.